PMID: 6409458Apr 1, 1983Paper

Serum free thyroxine concentration and free thyroid hormone indices in normal pregnancy

Clinical Endocrinology
M R HoptonJ S Harrop

Abstract

Serum free thyroxine (FT4) concentrations were shown to be significantly reduced at 36-38 weeks normal pregnancy, both as measured FT4 by the Amerlex method (P less than 0.001), and as calculated FT4 (P less than 0.001) using accepted molecular weight and affinity constant data for the binding proteins. Serum FT4 concentrations as determined by the Immophase method were normal at 36-38 weeks normal pregnancy. All methods gave normal serum FT4 concentrations in subjects taking the oral contraceptive pill. FT4I and FT3I, derived using the MAA T3 uptake-value, were higher than normal at 36-38 weeks pregnancy (P less than 0.001), whereas T4/TBG and T3/TBG were both reduced (P less than 0.001). The observation that serum FT4 concentrations may fall in late pregnancy, as demonstrated both by the Amerlex radioimmunoassay technique and by calculation, suggests that circulating FT4 may not be the sole determinant of thyroid status at this time. From a practical viewpoint, it is important to note that currently available direct and indirect methods of assessing serum FT4 concentrations produce different patterns of change in pregnancy.

References

Feb 19, 1977·British Medical Journal·W A BurrR Hoffenberg
Oct 1, 1977·Clinical Endocrinology·H P Princé, D B Ramsden
May 1, 1979·The Journal of Clinical Endocrinology and Metabolism·A HaradaA E Pekary
Sep 1, 1979·British Medical Journal·A KurtzR Ekins
May 1, 1976·The American Journal of the Medical Sciences·T W AvruskinC S Hollander
Jan 1, 1976·The Journal of Clinical Endocrinology and Metabolism·R OsathanondhI J Chopra
Dec 15, 1970·American Journal of Obstetrics and Gynecology·G D Malkasian, W E Mayberry
Feb 19, 1968·JAMA : the Journal of the American Medical Association·B G Anderson
Jul 3, 1973·Biochemistry·R A PagesH Edelhoch
Sep 1, 1969·The Journal of Clinical Endocrinology and Metabolism·N I RobinH A Selenkow
Jun 5, 1982·Lancet·N AminoO Tanizawa
Aug 7, 1982·Lancet·T A Wilkins, J E Midgley
Sep 1, 1981·Clinical Endocrinology·J R StockigtD M Hurley
Jun 12, 1982·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·J L Miller, J Smith
Nov 1, 1956·The Journal of Clinical Investigation·J T DOWLINGS H INGBAR
May 1, 1962·The Journal of Clinical Investigation·K STERLING, A HEGEDUS

❮ Previous
Next ❯

Citations

Jan 1, 1984·European Journal of Nuclear Medicine·J D Wiener
Jan 31, 1987·British Medical Journal·P E Belchetz
Mar 16, 2012·International Journal of General Medicine·Khalid A El Baba, Sami T Azar
Jan 1, 1987·Critical Reviews in Clinical Laboratory Sciences·G H White
Jul 1, 1991·Clinical Endocrinology·R Z KleinM L Mitchell
Sep 1, 1987·British Journal of Addiction·A CrawfordR W Latcham
Apr 1, 1986·Journal of Endocrinological Investigation·A PacchiarottiA Pinchera
Jan 11, 2005·Arquivos brasileiros de endocrinologia e metabologia·José Gilberto H VieiraRui M B Maciel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.